AARD
NASDAQ
$5.53
Aardvark Therapeutics Inc (AARD)
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $15.44 (+179.20%)
Market Cap
$146M
Free Cash Flow Yield
-42.43%
Beta (5Y)
1.75
Price Chart
Valuation
Market Cap$146M
P/B1.57
Profitability
EBITDA-$75M
EPS-$3.21
Financial Health
Free Cash Flow Yield-42.43%
Growth & Risk
Beta (5Y)1.75
Sharpe Ratio0.03